Financial News
Stories about Aimmune Therap
From Motley Fool
From Benzinga
From Motley Fool
2 Top Cancer Treatment Stocks To Watch In July
July 14, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For July 13, 2020
July 13, 2020
From Benzinga
Why DBV Technologies Is Plunging Today
June 26, 2020
From Motley Fool
Tags
Stocks
From Market News Video
Down 40% in 6 Months, Is Aimmune Therapeutics a Buy?
June 18, 2020
From Motley Fool
Tags
companyNews
From Motley Fool
From Motley Fool
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
May 10, 2020
From Benzinga
Tags
Stocks
From Market News Video
Is Aimmune Therapeutics a Buy?
April 17, 2020
From Motley Fool
From Motley Fool
From Motley Fool
Bargain Hunters Take Note: Insider Cluster-Buying At AIMT
March 24, 2020
Tags
Stocks
From Market News Video
10 Biggest Price Target Changes For Monday
March 23, 2020
From Benzinga
Tags
companyNews
UPDATE 1-Coronavirus begins disrupting clinical trials as companies try containing spread
March 18, 2020
Tags
companyNews
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
March 18, 2020
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.